{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:49:57Z","timestamp":1782175797160,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Guangdong Science and Technology Plan","award":["2013B020224003"],"award-info":[{"award-number":["2013B020224003"]}]},{"name":"Guangdong Science and Technology Plan","award":["2014A050503038"],"award-info":[{"award-number":["2014A050503038"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2015A030313095"],"award-info":[{"award-number":["2015A030313095"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"H7N9 Avian Influenza Joint Research","award":["2014-1046"],"award-info":[{"award-number":["2014-1046"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.vaccine.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T13:41:33Z","timestamp":1530970893000},"page":"5030-5036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice"],"prefix":"10.1016","volume":"36","author":[{"given":"Jianru","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouyang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.004_b0005","unstructured":"FAO H7N9 situation update \u2013 Avian influenza A (H7N9) virus. Food and Agriculture Organization of the United Nations. (2018). Available from: <http:\/\/www.fao.org\/ag\/againfo\/programmes\/en\/empres\/h7n9\/situation_update.html>."},{"key":"10.1016\/j.vaccine.2018.07.004_b0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.07.004_b0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5582\/bst.2017.01040","article-title":"Global concern regarding the fifth epidemic of human infection with avian influenza A (H7N9) virus in China","volume":"11","author":"Shen","year":"2017","journal-title":"Biosci Trends"},{"key":"10.1016\/j.vaccine.2018.07.004_b0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","article-title":"Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China","volume":"25","author":"Su","year":"2017","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES2014.19.25.20838","article-title":"Limited human-to-human transmission of avian influenza A(H7N9) virus, Shanghai, China, March to April 2013","volume":"19","author":"Hu","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2018.07.004_b0030","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1128\/JVI.03173-15","article-title":"Two outbreak sources of influenza A (H7N9) viruses have been established in China","volume":"90","author":"Wang","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0035","unstructured":"Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. World Health Organization. (2017). Available from: <http:\/\/www.who.int\/influenza\/vaccines\/virus\/201703_zoonotic_vaccinevirusupdate.pdf?ua=1>."},{"key":"10.1016\/j.vaccine.2018.07.004_b0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinf.2017.04.001","article-title":"Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China","volume":"75","author":"Zhang","year":"2017","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.07.004_b0045","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3201\/eid2308.170600","article-title":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China","volume":"23","author":"Ke","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.004_b0050","first-page":"1217","article-title":"Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in Mainland China","volume":"91","author":"Yang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2018.07.004_b0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/bab.1379","article-title":"Expression and characterization of hepatitis E virus-like particles and non-virus-like particles from insect cells","volume":"63","author":"Qi","year":"2016","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.vaccine.2018.07.004_b0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2006.12.014","article-title":"Human immunodeficiency virus-like particles activate multiple types of immune cells","volume":"362","author":"Sailaja","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.004_b0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.talanta.2017.07.046","article-title":"Quantitation and biospecific identification of virus-like particles of human papillomavirus by capillary electrophoresis","volume":"175","author":"Bettonville","year":"2017","journal-title":"Talanta"},{"key":"10.1016\/j.vaccine.2018.07.004_b0075","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1099\/jgv.0.000494","article-title":"The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles","volume":"97","author":"Ujike","year":"2016","journal-title":"J Gene Virol"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2018.07.004_b0080","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","article-title":"Large-scale production and purification of VLP-based vaccines","volume":"107","author":"Vicente","year":"2011","journal-title":"J Invertebr Pathol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0085","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/j.vaccine.2015.05.044","article-title":"Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.004_b0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virusres.2017.09.008","article-title":"Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice","volume":"242","author":"Wang","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.07.004_b0095","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1038\/s41598-017-18054-x","article-title":"Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.07.004_b0100","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s007050170002","article-title":"Universal primer set for the full-length amplification of all influenza A viruses","volume":"146","author":"Hoffmann","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0105","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.1128\/JVI.79.15.10003-10012.2005","article-title":"Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity","volume":"79","author":"Li","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11262-013-0924-0","article-title":"Mutations of two transmembrane cysteines of hemagglutinin (HA) from influenza A H3N2 virus affect HA thermal stability and fusion activity","volume":"47","author":"Xu","year":"2013","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2018.07.004_b0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11262-013-1011-2","article-title":"Recombinant influenza A H3N2 viruses with mutations of HA transmembrane cysteines exhibited altered virological characteristics","volume":"48","author":"Zhou","year":"2014","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2018.07.004_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.004_b0125","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1128\/JVI.03253-14","article-title":"Influenza virus M2 protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface","volume":"89","author":"Alvarado-Facundo","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0130","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.vaccine.2014.03.058","article-title":"Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.004_b0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11262-013-1021-0","article-title":"Evidences for the existence of intermolecular disulfide-bonded oligomers in the H3 hemagglutinins expressed in insect cells","volume":"48","author":"Xu","year":"2014","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2018.07.004_b0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0145","doi-asserted-by":"crossref","first-page":"7026","DOI":"10.1016\/j.vaccine.2017.10.051","article-title":"Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine","volume":"35","author":"Ni","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.004_b0150","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.07.004_b0155","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2017.09.007","article-title":"The Pathway to a universal influenza vaccine","volume":"47","author":"Paules","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.07.004_b0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2016.12.001","article-title":"Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens","volume":"501","author":"Pushko","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.004_b0165","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/0022-1317-79-7-1781","article-title":"An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus","volume":"79","author":"Vanlandschoot","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0170","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.07.004_b0175","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1214913110","article-title":"Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies","volume":"110","author":"Harris","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2018.07.004_b0180","doi-asserted-by":"crossref","first-page":"414a","DOI":"10.1016\/j.bpj.2012.11.2310","article-title":"Molecular structures of native HA trimers on 2009 H1N1 pandemic influenza virus complexed with neutralizing antibodies","volume":"104","author":"Harris","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2018.07.004_b0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinf.2015.06.009","article-title":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings","volume":"72","author":"Pan","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2018.07.004_b0190","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2018.07.004_b0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/cid\/cit638","article-title":"Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan","volume":"58","author":"Lin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.004_b0200","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/infdis\/jit430","article-title":"Avian-origin influenza A(H7N9) infection in influenza A(H7N9)-affected areas of China: a serological study","volume":"209","author":"Yang","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.07.004_b0205","first-page":"91","article-title":"Inactivated H7 influenza virus vaccines protect mice despite inducing only low levels of neutralizing antibodies","author":"Kamal","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0210","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/JVI.03095-13","article-title":"Divergent H7 immunogens offer protection from H7N9 virus challenge","volume":"88","author":"Krammer","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.004_b0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1750-2659.2009.00082.x","article-title":"A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models","volume":"3","author":"Cox","year":"2009","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18309344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:27:52Z","timestamp":1759400872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18309344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":43,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0264410X18309344"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H7 virus-like particles assembled by hemagglutinin containing H3N2 transmembrane domain and M1 induce broad homologous and heterologous protection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}